Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-17-001128
Filing Date
2017-07-05
Accepted
2017-07-05 20:24:12
Documents
1
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form4a-07052017_050702.html 4/A  
1 form4a-07052017_050702.xml 4/A 6028
  Complete submission text file 0001415889-17-001128.txt   7911
Mailing Address 229 WEST 60TH STREET NEW YORK NY 10023
Business Address
BALK MATTHEW (Reporting) CIK: 0001217674 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37853 | Film No.: 17950590

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 2422 WESTPORT CT 06880
Business Address PO BOX 2422 WESTPORT CT 06880 917-842-2353
Pelican Partners LLC (Reporting) CIK: 0001681335 (see all company filings)

State of Incorp.: DE
Type: 4/A | Act: 34 | File No.: 001-37853 | Film No.: 17950591